DE60312494D1 - Optisch aktives pyridinderivat und medikament, das dieses enthält - Google Patents

Optisch aktives pyridinderivat und medikament, das dieses enthält

Info

Publication number: DE60312494D1
Authority: DE; Germany
Prior art keywords: medicament; optically active; pyridine derivative; active pyridine; derivative
Prior art date: 2002-03-14
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Fee Related

Application number

DE60312494T

Other languages

English (en)

Other versions

DE60312494T2 (de

Inventor

Toshiki Murata

Sachiko Sakakibara

Takashi Yoshino

Hiroki Sato

Yuji Koriyama

Noriko Nunami

Megumi Yamauchi

Keiko Fukushima

Rolf Grosser

Kinji Fuchikami

Kevin Bacon

Timothy Lowinger

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Bayer Pharma AG

Original Assignee

Bayer Healthcare AG

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-03-14

Filing date

2003-03-03

Publication date

2007-04-26

2003-03-03 Application filed by Bayer Healthcare AG filed Critical Bayer Healthcare AG

2007-04-26 Publication of DE60312494D1 publication Critical patent/DE60312494D1/de

2007-11-29 Application granted granted Critical

2007-11-29 Publication of DE60312494T2 publication Critical patent/DE60312494T2/de

2023-03-04 Anticipated expiration legal-status Critical

Status Expired - Fee Related legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Physical Education & Sports Medicine (AREA)
Dermatology (AREA)
Rheumatology (AREA)
Pulmonology (AREA)
Pain & Pain Management (AREA)
Orthopedic Medicine & Surgery (AREA)
Communicable Diseases (AREA)
Toxicology (AREA)
Diabetes (AREA)
Hematology (AREA)
Ophthalmology & Optometry (AREA)
Urology & Nephrology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Oncology (AREA)
Transplantation (AREA)
Vascular Medicine (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

DE60312494T 2002-03-14 2003-03-03 Optisch aktives pyridinderivat und medikament, das dieses enthält Expired - Fee Related DE60312494T2 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
JP2002070655		2002-03-14
JP2002070655A JP2003277383A (ja)	2002-03-14	2002-03-14	光学活性ピリジン誘導体およびそれを含む医薬
PCT/EP2003/002169 WO2003076447A1 (en)	2002-03-14	2003-03-03	An optically acitve pyridine derivative and a medicament containing the same

Publications (2)

Publication Number	Publication Date
DE60312494D1 true DE60312494D1 (de)	2007-04-26
DE60312494T2 DE60312494T2 (de)	2007-11-29

Family

ID=27800344

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DE60312494T Expired - Fee Related DE60312494T2 (de)	2002-03-14	2003-03-03	Optisch aktives pyridinderivat und medikament, das dieses enthält

Country Status (13)

Country	Link
US (2)	US7375103B2 (de)
EP (1)	EP1487842B1 (de)
JP (2)	JP2003277383A (de)
AR (1)	AR038950A1 (de)
AU (1)	AU2003215624A1 (de)
CA (1)	CA2478942A1 (de)
DE (1)	DE60312494T2 (de)
ES (1)	ES2283795T3 (de)
HN (1)	HN2003000098A (de)
PE (1)	PE20040242A1 (de)
TW (1)	TW200403247A (de)
UY (1)	UY27719A1 (de)
WO (1)	WO2003076447A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE102005036655A1 (de) *	2005-08-04	2007-02-08	Bayer Healthcare Ag	Behandlung von Tumoren mit IKK-ß Inhibitoren
US8426355B2 (en)	2006-03-15	2013-04-23	Theralogics, Inc.	Methods of treating muscular wasting diseases using NF-κB activation inhibitors
WO2008044339A1 (en) *	2006-10-13	2008-04-17	Aqumen Biopharmaceuticals K.K.	Therapeutic/preventive agent for intraocular disease containing statin compound
US11969501B2 (en)	2008-04-21	2024-04-30	Dompé Farmaceutici S.P.A.	Auris formulations for treating otic diseases and conditions
BRPI0910850B1 (pt)	2008-04-21	2022-06-14	Otonomy, Inc.	Composição intratimpânica compreendendo fator neurotrófico de crescimento derivado do cérebro (bdnf) para o tratamento ou prevenção da perda auditiva
JP6368353B2 (ja)	2013-04-08	2018-08-01	バイエルファーマアクチエンゲゼルシャフト	置換された２，３−ジヒドロイミダゾ［１，２−ｃ］キナゾリン類のリンパ腫治療への使用
TW201701879A (zh)	2015-04-30	2017-01-16	拜耳製藥公司	Ｉｒａｋ４抑制劑組合
JP6947743B2 (ja)	2016-03-03	2021-10-13	バイエル・ファルマ・アクティエンゲゼルシャフト	新規な２−置換インダゾール、その製造方法、それを含有する医薬製剤、および薬物を製造するためのその使用
EP3478269A4 (de)	2016-06-29	2020-04-08	Otonomy, Inc.	Triclyceridformulierungen für das ohr und verwendungen davon

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP4272338B2 (ja) *	2000-09-22	2009-06-03	バイエルアクチェンゲゼルシャフト	ピリジン誘導体

2002
- 2002-03-14 JP JP2002070655A patent/JP2003277383A/ja active Pending
2003
- 2003-03-03 WO PCT/EP2003/002169 patent/WO2003076447A1/en not_active Ceased
- 2003-03-03 CA CA002478942A patent/CA2478942A1/en not_active Abandoned
- 2003-03-03 US US10/508,107 patent/US7375103B2/en not_active Expired - Fee Related
- 2003-03-03 ES ES03743829T patent/ES2283795T3/es not_active Expired - Lifetime
- 2003-03-03 JP JP2003574663A patent/JP2005526074A/ja active Pending
- 2003-03-03 DE DE60312494T patent/DE60312494T2/de not_active Expired - Fee Related
- 2003-03-03 EP EP03743829A patent/EP1487842B1/de not_active Expired - Lifetime
- 2003-03-03 AU AU2003215624A patent/AU2003215624A1/en not_active Abandoned
- 2003-03-12 AR ARP030100859A patent/AR038950A1/es not_active Application Discontinuation
- 2003-03-12 UY UY27719A patent/UY27719A1/es not_active Application Discontinuation
- 2003-03-13 PE PE2003000253A patent/PE20040242A1/es not_active Application Discontinuation
- 2003-03-13 TW TW092105417A patent/TW200403247A/zh unknown
- 2003-03-13 HN HN2003000098A patent/HN2003000098A/es unknown
2008
- 2008-05-19 US US12/123,405 patent/US20090054424A1/en not_active Abandoned

Also Published As

Publication number	Publication date
ES2283795T3 (es)	2007-11-01
EP1487842B1 (de)	2007-03-14
HN2003000098A (es)	2003-12-15
AU2003215624A1 (en)	2003-09-22
PE20040242A1 (es)	2004-05-15
TW200403247A (en)	2004-03-01
EP1487842A1 (de)	2004-12-22
DE60312494T2 (de)	2007-11-29
US20050215547A1 (en)	2005-09-29
JP2005526074A (ja)	2005-09-02
WO2003076447A1 (en)	2003-09-18
US7375103B2 (en)	2008-05-20
US20090054424A1 (en)	2009-02-26
AR038950A1 (es)	2005-02-02
UY27719A1 (es)	2003-10-31
CA2478942A1 (en)	2003-09-18
JP2003277383A (ja)	2003-10-02

Publication	Publication Date	Title
DE60328481D1 (de)	2009-09-03	Schleimhautapplizierter impfstoff, der das adjuvanz chitosan und menigokokkenantigene enthält
ATE483698T1 (de)	2010-10-15	5-(benz- (z) -yliden) -thiazolidin-4-onderivate als das immunsystem unterdrückende mittel
DE50013608D1 (de)	2006-11-23	PIEZOELEKTRISCHER ANTRIEB, sowie System mit piezoelektrischem Antrieb und Schaltungsanordnung
DE60336093D1 (de)	2011-03-31	Selbstverschliessende Kanüle
DE60327230D1 (de)	2009-05-28	Pentosezucker fermentierende zymomonas-stämme und verwendungen davon
DE60324099D1 (de)	2008-11-27	Arzneistoffhaltiger tampon
DE60017716D1 (de)	2005-03-03	Coextrudierte medizinische multilumenleitung
NO20053224D0 (no)	2005-07-01	Patient controlled drug administration device.
PT1500654E (pt)	2006-06-30	Derivados de benzoxazinona, sua preparacao e utilizacao como medicamentos
FR2843964B1 (fr)	2004-10-01	Derives de dioxane-2-alkylcarbamates, leur preparation et leur application en therapeutique
ATE479437T1 (de)	2010-09-15	Benzoä4,5üthienoä2,3-düpyrimidin-4-one und ihre therapeutische verwendung
FI20022225A0 (fi)	2002-12-18	Sykerajan asettaminen sykemittarissa
MA27233A1 (fr)	2005-02-01	Derives de piperazinylacylpiperidine, leur preparation et leur application en therapeutique
DE60309169D1 (de)	2006-11-30	Verwendung vom pullulan als langsam verdauliches kohlenhydrat
EP1570270A4 (de)	2010-09-22	Therapeutische biokonjugate
DE60234388D1 (de)	2009-12-24	Therapeutische lotion gegen dermatitis
NL1023790A1 (nl)	2004-02-03	Farmaceutische samenstellingen met antibiotische activiteit.
DE60312494D1 (de)	2007-04-26	Optisch aktives pyridinderivat und medikament, das dieses enthält
DE60016363D1 (de)	2005-01-05	Aminoalkohol-Derivat und Medikament, das dieses Derivat enthält
DE60326734D1 (de)	2009-04-30	Ligations-behandlungsgerät
FR2870846B1 (fr)	2006-08-04	Derives de tetrahydroisoquinolylsulfonamides, leur preparation et leur utilisation en therapeutique
FR2845388B1 (fr)	2004-11-12	Derives de 1,4-diazabicyclo[3.2.2]nonanecarboxamides, leur preparation et leur application en therapeutique
ITMI20020297A0 (it)	2002-02-15	Cerniera per mobili perfezionata
FI20021617A0 (fi)	2002-09-10	Diagnostisia ja terapeuttisia menetelmiä
IS7902A (is)	2005-06-20	Blettaeyðandi samsetning fyrir húðumhirðu

Legal Events

Date	Code	Title	Description
2008-04-03	8364	No opposition during term of opposition
2009-09-10	8327	Change in the person/name/address of the patent owner	Owner name: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT, 1335, DE
2011-01-20	8339	Ceased/non-payment of the annual fee